Simons says: The Tipline for 29 January 2021
Outgoing Federal Trade Commission chair Joseph Simons is not a man of many words, but he is a man of many decisive votes. The agency squeezed out one more monopolisation case this week before Simons left his virtual office for the very last time. In the final Tipline of the FTC’s Simons era, GCR USA explores the agency’s challenge to a second reverse-payment settlement between Endo Pharmaceuticals and Impax Laboratories and takes a glance at the origins of the Department of Justice’s automakers emissions probe.
Subscribe to Global Competition Review
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10